NCT/Study#
NCT04164082 /
A031803
Phase II Trial Of Intravesical Gemcitabine And MK-3475 (Pembrolizumab) In The Treatment Of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
DISEASE GROUP:
Genito-Urinary
current phase:
Phase II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
